The DOL order announcement shows that the department is still moving ahead with at least some enforcement actions.

Harris spent 21 years as a news anchor and correspondent at ABC News, where he hosted Nightline and the weekend editions of ...

Underscoring these concerns, nearly half of insured adults (46%) say that lowering out-of-pocket costs is the change they'd ...

Carl Hess, the chief executive officer of Willis Towers Watson, talked about the mixed effects of upheaval on employers' ...

Regulators are facing pressure to act in the growing disagreement over claims-data requirements.

One solution to escalating costs might be changing how plans provide primary care.

There's a lot going on in the benefits industry right now for advisors to be excited about, including new cost-containment ...

Lawmakers talked about the cost-shifting problem Tuesday, at a committee hearing featuring the chief executive officers of ...

Regeneron will provide Otarmeni — a new gene therapy for an ultra-rare form of genetic hearing loss recently approved by the ...

Capital Blue Cross is partnering with the Mark Cuban Cost Plus Drug Co. to make lower‑cost biosimilar alternatives to Humira ...

In many cases, that leaves employers carrying GLP-1 costs without a clear return on investment. "We're finding that it does take a triage period to find out why people are on GLP-1s," Bigler added.

"What leads to greatness is being willing to realize you don't know everything and continue to work on things throughout your entire career," Hamm says. Good vs. great Many benefits advisors are in ...